Ankara Oncology Hospital Phase-1 Cancer Drug Research Center was established.
Ankara Oncology Training and Research Hospital Chief Physician. Dr. Fevzi Altuntaş stated that  Phase-I Cancer Drug Research Center was established within the hospital.

He stated that the hospital has a wide infrastructure in cancer. Dr. Altuntaş gave the following information: A full-scale cancer research center was established with clinical pharmacy practices, center of clinical research, good clinical practice as well as the Phase-I drug research and development center. With this center, we will conduct clinical research in the field of cancer and we will achieve the production of medicines. We will have a new hope for the patients. Phase-I operation; represents the first clinical onset of a new drug. It is often the stage in which a drug or molecule is first tested in humans.

The opening of the new research center will be performed in 16 January 2019, Klinar will be attending to the opening of the Phase I Center as a participating CRO.